Gimsilumab completes phase I study in development of gimsilumab for COVID-19-related ARDS March 30, 2020 No Comments
First-in-human long-term data presented for hAECs in extremely preterm infants March 27, 2020 No Comments
Dupixent approved for additional indication of chronic rhinosinusitis with nasal polyp March 26, 2020 No Comments
Roivant seeks to advance development of gimsilumab for COVID-19-related ARDS March 20, 2020 No Comments
RSS